Skip to main content
. Author manuscript; available in PMC: 2014 Jul 31.
Published in final edited form as: Antivir Ther. 2013 Jul 31;18(8):1005–1013. doi: 10.3851/IMP2665

Figure 4. The correlation between cervicovaginal fluid (CVF) and genital tissue dolutegravir (DTG) concentrations.

Figure 4

Individual concentration/time points are plotted for DTG in genital tract tissues and in CVF. a) Presents cervical tissue (circles) and vaginal tissues (squares) correlated with CVF following the first dose of DTG. b) Presents vaginal tissue (circles) and vaginal tissues (squares) correlated with CVF after multiple dosing. The correlation between CVF and genital tissues (GT) at PK1 is 0.16 (p=0.55), and between CVF and GT at PK2 is 0.52 (p=0.04). A line of unity is presented as reference.